Benefits and risks of danazol in hereditary angioedema: a long-term survey of 118 patients
- 29 February 2008
- journal article
- research article
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 100 (2), 153-161
- https://doi.org/10.1016/s1081-1206(10)60424-3
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Missense mutations in the coagulation factor XII (Hageman factor) gene in hereditary angioedema with normal C1 inhibitorBiochemical and Biophysical Research Communications, 2006
- Hereditary Angioedema: New Findings Concerning Symptoms, Affected Organs, and CourseThe American Journal of Medicine, 2006
- Hepatocellular Focal Nodular Hyperplasia after Danazol Treatment for Hereditary Angio-oedemaActa Dermato-Venereologica, 2006
- Adverse effects of danazol prophylaxis on the lipid profiles of patients with hereditary angioedemaJournal of Allergy and Clinical Immunology, 2005
- Efficacy of danazol treatment in a patient with the new variant of hereditary angio-oedema (HAE III)British Journal of Dermatology, 2004
- Asphyxiation by Laryngeal Edema in Patients With Hereditary AngioedemaMayo Clinic Proceedings, 2000
- Local bradykinin generation in hereditary angioedema☆☆☆★Journal of Allergy and Clinical Immunology, 1999
- Danazol induced pancreatitis and hepatitisClinical Rheumatology, 1990
- Clinical and biochemical effects of stanozolol therapy for hereditary angioedemaJournal of Allergy and Clinical Immunology, 1981
- Danazol in the Treatment of Hereditary AngioedemaDrugs, 1980